1. Israel Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Compugen Ltd.

Compugen Ltd.

CGEN.TA
Compugen Ltd.IL flagTel Aviv Stock Exchange
700.50
ILA
+0.80
- -
662.35MMarket Cap

Total Valuation

Compugen Ltd. carries a market capitalization of 662.35M, placing it among publicly traded companies globally. Its enterprise value stands at 19.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap662.35M
Enterprise Value19.45B

Share Statistics

Compugen Ltd. currently has 94.58M shares outstanding.

Shares Outstanding94.58M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Compugen Ltd. trades at a trailing price-to-earnings ratio of 561.92.

PE Ratio561.92
PS Ratio269.57
PB RatioN/A
P/TBV Ratio205.40
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

The EV/Sales ratio of 267.75 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 633.59 provides insight into valuation relative to core operating earnings.

EV / Sales267.75
EV / EBITDA633.59
EV / EBIT633.59
EV / FCFN/A

Financial Position

Compugen Ltd. maintains a current ratio of 6.23, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities.

Current Ratio6.23
Quick Ratio6.23
Debt / Equity3.07
Debt / EBITDA0.10
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)26.68
Return on Invested Capital (ROIC)38.79
Return on Capital Employed (ROCE)1,222.34
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Compugen Ltd. has paid 28,000.00 in income taxes, reflecting an effective tax rate of 0.08.

Income Tax28,000.00
Effective Tax Rate0.08

Stock Price Statistics

Compugen Ltd.'s stock has gained approximately 18.02864% over the past 52 weeks. The 50-day moving average sits at 716.60, while the 200-day moving average is 622.45.

Beta (5Y)N/A
52-Week Price Change18.02864%
50-Day Moving Average716.60
200-Day Moving Average622.45
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Compugen Ltd. generated 72.66M in revenue and converted that into 34.86M in net income, yielding earnings per share of 0.37. EBITDA reached 30.70M, while operating income came in at 30.70M.

Revenue72.66M
Gross Profit63.98M
Operating Income30.70M
Pretax Income34.88M
Net Income34.86M
EBITDA30.70M
EBIT30.70M
Earnings Per Share (EPS)0.37

Balance Sheet

Compugen Ltd. holds 134.95M in cash and equivalents against 2.93M in total debt, resulting in a net debt position of -12.43M.

Cash & Cash Equivalents134.95M
Total Debt2.93M
Net Debt-12.43M
Equity (Book Value)N/A
Book Value Per ShareN/A
Working Capital115.25M

Margins

Compugen Ltd. operates with a gross margin of 88.06, reflecting its pricing power and cost economics. The operating margin of 42.26 and net profit margin of 47.97 provide insight into operational efficiency.

Gross Margin88.06
Operating Margin42.26
Pretax Margin48.01
Profit Margin47.97
EBITDA Margin42.26

Scores

Compugen Ltd. posts an Altman Z-Score of 234.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score234.81